Notice of Change to Key Dates for PAR-23-308, Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)
Notice Number:
NOT-CA-24-011

Key Dates

Release Date:

December 01, 2023

Related Announcements

  • October 05, 2023 - Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional). See NOFO PAR-23-308

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to correct the Matrix of Key Dates (i.e., Application Due Dates, Review and Award Cycles) for PAR-23-308, Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional).

The following section of PAR-23-308 has been corrected:

Part 1. Overview Information, Key Dates

Currently, it reads:

Application Due DatesReview and Award Cycles
NewRenewal / Resubmission / Revision (as allowed)AIDS - New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
January 16, 2024January 16, 2024Not ApplicableJune 2024August 2024October 2024

Expiration Date: January 17, 2024

Corrected to read (in bold italics):

Application Due DatesReview and Award Cycles
NewRenewal / Resubmission / Revision (as allowed)AIDS - New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
January 16, 2024January 16, 2024Not ApplicableJune 2024August 2024October 2024
October 9, 2024October 9, 2024Not ApplicableJanuary 2025May 2025July 2025
October 9, 2025October 9, 2025Not ApplicableJanuary 2026May 2026July 2026

Expiration Date: October 10, 2025

All other aspects of PAR-23-308 remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Sandra L. San Miguel-Majors, DrPH, M.S.
National Cancer Institute (NCI)
Telephone: 240-276-5977
Email: [email protected]

Behrous Davani, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6170
Email: [email protected]

LeeAnn Bailey, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6170
Email: [email protected]

Peer Review Contact(s)

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: [email protected]

Financial/Grants Management Contact(s)

Dawn Mitchum
National Cancer Institute (NCI)
Telephone: 202-276-5699
Email: [email protected]